期刊文献+

健脾清热活血类方药对溃疡性结肠炎肠黏膜功能障碍及claudin-2、claudin-5的影响 被引量:8

The mechanism of Jian Pi Qing Re Huo Xue decoction on improving colon mucosa dysfunction and regulating the expression of claudin-2 and claudin-5 in DSS-induced colitis
原文传递
导出
摘要 [目的]基于检测溃疡性结肠炎结肠黏膜组织形态、超微结构、上皮紧密连接,及紧密连接蛋白claduin-2、claudin-5表达的变化,探讨健脾清热活血方防治溃疡性结肠炎的可能机制。[方法]72只雄性Balb-c小鼠按体重随机分为6组,即正常组、模型组、对照组、治疗组(低、中、高剂量),每组12只。除正常组外,其余各组小鼠均采用自由饮用3%DSS 6周法制备溃疡性结肠炎模型,自第7周起分组给药,模型组予等剂量生理盐水,对照组予艾迪莎,治疗组予不同剂量健脾清热活血方,连续给药4周,第11周末处死全部小鼠。应用光镜、透射电镜及免疫组织化学观察结肠黏膜组织形态、超微结构及黏蛋白变化;应用荧光定量PCR技术检测紧密连接蛋白claudin-2、claduin-5表达变化。[结果]模型组光镜下见结肠黏膜不同程度缺损、溃疡形成,表面可见坏死组织,以及隐窝脓肿形成;电镜下见肠上皮细胞表面微绒毛稀疏,细胞连接间隙增宽,杯状细胞减少,线粒体肿胀,结构不清或呈空泡变,部分可见核固缩,并见凋亡小体;结肠黏蛋白分泌下降。治疗组光镜下见结肠黏膜充血肿胀、少量炎性细胞浸润,可见隐窝脓肿,未见明显溃疡;电镜下见肠上皮细胞表面绒毛排列尚整齐,可见线粒体肿胀,核固缩及凋亡小体;结肠黏蛋白分泌增加,与模型组比较,有统计学意义(P<0.05)。模型组claudin-2表达呈上升趋势、claudin-5表达呈下降趋势;治疗组claudin-2表达下降及claudin-5表达上升,经比较有统计学意义(P<0.05)。[结论]健脾清热活血方药可能通过降低claudin-2表达、上升claudin-5表达,促进黏膜修复,达到缓解溃疡性结肠炎的效用。 [Objective]We aim to explore the mechanism of Jian pi qing re huo xue decoction by observa- tion the colon mucosa morphology, ultrastructure and epithelial tight junctions which based on the changed expression of claduin-2,claudin-5 before and after the treatment of ulcerative colitis. [Methods] 72 Balb-c rats were randomly divided into the normal group, the blank group, the control group and the intervention group equally. Except normal group,other groups were administrated by drinking 3 % DSS for six weeks to making ulcerative colitis model. Since the seventh week, the blank group was given with the same doses of saline, the control group was treated with Editha, and the intervention group was given with different doses of Jianpiqingrehuoxue decoction for 4 weeks. All rats were killed at the eleventh week. The colon mucosa morphology, ultrastructure and the changed expression of mucin were detected by the light microscopy, the electron microscopy and the immuno histochemistry. The expression of tight junction protein including Claudin-2 ,claduin-5 were detected by the real-time PCR. [Results]There were different degrees of defected colonic mucosa,ulceration and crypt abscess with necrotic tissue on surface under light microscope in the blank group. Also there were microvilli sparse on the intestinal epithelial cell, the intercellular spaces, the decreased goblet cells,the swelling mitochondria, the unclear structure with vacuolar degeneration, the py- knosis nuclear and apoptotic bodies under the electron microscope. The colonic mucin secretion was de- creased. There was colonic mucosal hyperemia with swelling,inflammatory cell infiltration, and crypt ab- scess without obvious ulcer in the treatment group under light microscope. Also the intestinal epithelial cells were still neatly arranged with swelling mitochondrion, nuclear condensation and apoptotic bodies on the surface under electron microscope. The colonic mucin secretion was in the increasment. There was a statistical difference compared with the blank group(P〈0.05). The expression of Claudin-2 in blank group was on a rising trend,and the expression of claudin-5 was decreased. The expression of Claudin-2 in inter vention group was on the decline, and the expression of claudin-5 was on the rise. There were statistical difference(P〈0. 05). {-Conelusion]Jian pi qing re huo xue decoction can promote mucosal repair in order to remitting ulcerative colitis through regulating the expression of Claudin-2 and claudin-5.
出处 《中国中西医结合消化杂志》 CAS 2015年第9期599-603,607,共6页 Chinese Journal of Integrated Traditional and Western Medicine on Digestion
基金 国家自然基金(No:81260536) 广西自然基金(No:2013GNSFAA019116)
关键词 claudin-2 CLAUDIN-5 肠黏膜功能障碍 溃疡性结肠炎 健脾清热活血方 claudin-2 claudin-5 intestinal mucosa dysfunction ulcerative colitis Jian pi qing re huo xuedecoction
  • 相关文献

参考文献15

  • 1DANESE S,RUDZISKI J,BRANDT W,et al.Tralokinumab for moderate-to-severe UC:a randomised,double-blind,placebo-controlled,phase IIa study[J].Gut,2015,64:243-249.
  • 2GYIRES K,TTHV,ZDORI S Z.Gut inflammation:current update on pathophysiology,molecular mechanism and pharmacological treatment modalities[J].Curr Pharm Des,2014,20:1063-1081.
  • 3ALGABA A,LINARES P M,FERNNDEZ-CONTRERAS M E,et al.Relationship between levels of angiogenic and lymphangiogenic factors and the endoscopic,histological and clinical activity,and acutephase reactants in patients with inflammatory bowel disease[J].J Crohns Colitis,2013,7:e569-e579.
  • 4MCGUCKIN M A,HASNAIN S Z.There is a‘uc’in mucus,but is there mucus in UC[J]?Gut,2014,63:216-217.
  • 5NIGHOT P,YOUNG K,NIGHOT M,et al.Chloride channel ClC-2is a key factor in the development of DSS-induced murine colitis.Inflamm[J].Bowel Dis.2013;19:2867-2877.
  • 6陈奇主编.中药药理临床实验方法学[M].3版.北京:人民卫生出版社,2012:1123-1135.
  • 7李华燕,张涛,张颖芹.健脾清热活血方与美沙拉嗪治疗溃疡性结肠炎的对比研究[J].中国中西医结合消化杂志,2011,19(4):227-230. 被引量:25
  • 8王喜周,张涛,陈远能,黄适,潘怀耿.健脾清热活血类方药介导β-catenin、C-myc表达干预溃疡性结肠炎相关癌变研究[J].中成药,2012,34(2):226-229. 被引量:17
  • 9SCHULZKE J D,PLOEGER S,AMASHEH M,et al.Epithelial tight junctions in intestinal inflammation[J].Ann N YAcad Sci,2009,1165:294-300.
  • 10HERING N A,SCHULZKE J D.Therapeutic options to modulate barrier defects in inflammatory bowel disease[J].Dig Dis,2009,27:450-454.

二级参考文献23

  • 1陈治水,危北海,张万岱,李道本.溃疡性结肠炎中西医结合诊治方案(草案)[J].中国中西医结合消化杂志,2005,13(2):133-136. 被引量:182
  • 2中国炎症性肠病协作组,王玉芳,欧阳钦.3100例溃疡性结肠炎住院病例回顾分析[J].中华消化杂志,2006,26(6):368-372. 被引量:267
  • 3中华医学会消化病分会炎症性肠病协作组.对我国炎症性肠病诊断治疗规范的共识意见.胃肠病学,8(12):487-495.
  • 4IRVINE E J, YEH C H, RAMSEY D, et al. The effect of mesalazine therapy on quality of life in patients with mildly and moderately active ulcerative colitis[J]. Aliment Pharmacol Ther, 2008,28 : 1278-- 1286.
  • 5中华中医药学会.中医内科常见疾病诊疗指南·西医疾病部分[M].北京:中国中医药出版社,2008:107-109.
  • 6CORTOT A, MAETZ D, DEGOUTTE E, et al. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis[J]. Am J Gastroenterol,2008,103 : 3106--3114.
  • 7MARAKHOUSKI Y, FIXA B, HOLOMAN J, et al. A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis[J]. Aliment Pharmacol Ther, 2005,21 :133-- 140.
  • 8ARDIZZONE S, MACONI G, RUSSO A, et al. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis[J]. Gut, 2006,55 : 47-- 53.
  • 9Nathan C,Ding A.Nonresolving inflammation[J].Cell,2010,140(6):871-82.
  • 10Mantovani A,Allavena P,Sica A,et al.Cancer-related inflam-mation[J].Nature,2008,454(7203):436-44.

共引文献33

同被引文献133

引证文献8

二级引证文献208

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部